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Design and development of nucleic acid targeted drugs is a challenging enterprise but real 
breakthroughs have been made in recent years[1-3]. Since DNA plays a fundamental role in 
normal cellular physiology and pathophysiology, it represents one of the most important 
molecular target of several chemotherapeutic drugs [4]. In particular, the discovery of 
nonpeptide-based DNA interactive drugs constituted one of the major goal. In fact, such 
agents offer the potential to interact with their intended target without falling hostage to 
cellular peptidases [1,3]. In this context, molecular recognition of DNA by polycyclic 
heterocycles having a planar structure bearing appropriate side chains have been widely 
investigated.  
In the course of our work aimed at developing novel heterocycles of pharmaceutical 
interest, we designed and synthetized several templates as potential substrate in drug 
design. In particular, by adopting different strategies, we obtained a set of condensed ring 
systems (I-IV) as versatile structural platforms to be functionalized as possible DNA-
interactive agents by intercalation and/or reversible enzyme inhibition such as 
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(by chromophore dimerization) derivatives
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Herein, we report the synthesis of these new tricyclic and tetracyclic heteroaromatic 
systems and a first series of their derivatives as well as docking studies performed to 
investigate a possible DNA-binding mode of some model compounds.  
Also, preliminary antiproliferative activity and other biological properties of these 
compounds are currently under investigation. 
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